saypha® filler

saypha® filler¹

  • Indication

    The viscoelastic implant is indicated to correct moderate to severe nasolabial folds.

  • Injection depth

    Mid to deep dermis

Ingredients

  • Concentration HA

    2.3 % (23 mg/mL)
    High molecular weight hyaluronic acid of non-animal origin

  • Crosslinking agent

    BDDE (concentration ≤ 2 ppm)

Packaging

  • Packaging unit

    1 box of 1 mL syringe

  • Needle

    2 x 27 G x 1/2" thin wall Terumo™ needle (CE 0197)

Questions?

Get in touch with a representative at our booth.

Related Products

saypha® rich

saypha® volume plus Lidocaine

saypha® volume

Lidocaine

saypha® volume

saypha® filler

Lidocaine

saypha® lips

Lidocaine

¹ Instruction for Use (IFU)
The healthcare professional confirms having informed the consumer of a likely risk associated with the use of the device in line with its intended use. For risks and adverse events associated with the use of the device consult the instructions of use.​

Saypha: CE 0123